NanoEnTek Inc
KOSDAQ:039860
NanoEnTek Inc
NanoenTek, Inc. engages in the manufacture and sale of diagnostics and analytical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-08-16. is a Korea-based company mainly engaged in the manufacturing of point of care testing (POCT) medical equipment and biotechnology research equipment. The Company’s products consist of Countess, EVE and ADAM, which are cell counting systems; NEON, which are gene delivery systems; JuLI, which are fluorescence microscopes, and chips, which are consumables of cell counting systems. The company also provides diagnostic medical equipment, such as FREND systems, which are quantitative immunoassay analyzing devices; ADAM-rWBC, an analytical device for counting the number of residual white blood cells (rWBCs) in leukoreduced blood products, and others. The firm distributes its products within domestic market and to overseas markets.
NanoenTek, Inc. engages in the manufacture and sale of diagnostics and analytical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-08-16. is a Korea-based company mainly engaged in the manufacturing of point of care testing (POCT) medical equipment and biotechnology research equipment. The Company’s products consist of Countess, EVE and ADAM, which are cell counting systems; NEON, which are gene delivery systems; JuLI, which are fluorescence microscopes, and chips, which are consumables of cell counting systems. The company also provides diagnostic medical equipment, such as FREND systems, which are quantitative immunoassay analyzing devices; ADAM-rWBC, an analytical device for counting the number of residual white blood cells (rWBCs) in leukoreduced blood products, and others. The firm distributes its products within domestic market and to overseas markets.
